Oncolytics Biotech Inc. (ONCY) Financials

ONCY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 7.7 million 13.8 million
March 31, 2026 8.2 million 13.3 million
Dec. 31, 2025 7.6 million 11.4 million
Sept. 30, 2025 15.1 million 14.9 million

ONCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.3 million 880884
March 31, 2026 -7.3 million 2.3 million
Dec. 31, 2025 -6.7 million -1.1 million
Sept. 30, 2025 -4.6 million 2.9 million

ONCY Net Income

No data available :(

ONCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 4.1 million - -
March 31, 2026 5.5 million - 508000
Dec. 31, 2025 5.2 million - 563000
Sept. 30, 2025 12.4 million - 835000

ONCY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 119.7 million
March 31, 2026 112.3 million
Dec. 31, 2025 108.0 million
Sept. 30, 2025 101.3 million

ONCY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 8367 4.3 million 5.1 million -
March 31, 2026 6000 4.6 million 4.7 million -
Dec. 31, 2025 970 3.0 million 6.9 million -
Sept. 30, 2025 5029 5.4 million 4.5 million -

ONCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 22313
Dec. 31, 2025 - -
Sept. 30, 2025 - 79000

ONCY

Price: $0.60

52 week price:
0.60
1.51

Earnings Per Share: -0.34 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 110000

Market Capitalization: 88.3 million

Links: